01:54 PM EDT, 08/07/2025 (MT Newswires) -- Cabaletta Bio ( CABA ) filed a shelf registration statement with US regulators on Thursday for the potential sale of up to $240 million in securities, to be offered from time to time in one or more tranches.

The filing covers common and preferred stock, debt securities, warrants and units.

The company plans to use net proceeds for general corporate purposes.

Price: 1.40, Change: -0.05, Percent Change: -3.79